TSS:Hg 122635.1

Basic information about the TSS

---

TSS ID: hg_122635.1 Species: human Chr: chr11		Start: 118902692 End: 118902696 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: AK122882 Distance: 346 GeneID: 283149 HGNC/MGI_ID: HGNC:23688 UniProt_ID:

Gene_name: BCL9 like Gene_symbol: BCL9L Gene_synonyms: B9L Bcl9-2 DLNB11 Gene_source: HGNC:23688

TATA-Box annotation

---

Distance to TSS:	7848
Nearest PromoterID:	NM_182557
Entrez ID:	283149
Nearest Unigene:	Hs.414740
Nearest Refseq:	NM_182557
Nearest Ensembl:	ENSG00000186174
Gene Name:	BCL9 like
Gene Alias:	B9L|BCL9-2|DLNB11
Gene Description:	BCL9 like
Gene Type:	protein-coding
CpG%:	0.03
GC%:	0.716418
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BCL9L p2@BCL9L p3@BCL9L p4@BCL9L p5@BCL9L p6@BCL9L
Sample		p1@BCL9L	p2@BCL9L	p3@BCL9L	p4@BCL9L	p5@BCL9L	p6@BCL9L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	2.73	0.19	0.19	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	3.84	0.00	0.20	0.20	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	2.31	0.19	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.25	0.00	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	3.15	0.22	0.22	0.22	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	2.33	0.00	0.00	0.19	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.09	0.22	0.00	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.15	0.24	0.00	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	3.42	0.43	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.22	0.00	0.58	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.02	0.00	0.40	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	2.85	0.41	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	36.43	2.42	0.97	2.10	0.97	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.93	4.06	0.30	2.10	1.35	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.37	2.63	0.88	2.20	0.44	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.17	3.77	0.50	2.01	1.76	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.30	2.40	0.87	3.06	0.44	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	26.57	2.11	0.42	5.91	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.26	3.73	0.53	2.13	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.01	5.42	0.45	3.01	0.30	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	40.76	6.01	0.40	4.14	0.94	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.19	4.83	0.69	3.11	1.21	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.48	5.04	1.03	2.84	0.52	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.28	3.64	0.97	3.15	0.97	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	48.24	6.19	0.52	3.87	1.03	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	46.84	6.96	1.58	2.53	1.90	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	43.41	3.30	0.55	6.04	0.00	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	85.34	6.84	1.41	6.37	0.94	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	62.35	5.81	0.97	8.24	1.62	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	74.74	4.89	1.45	4.89	1.09	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	45.22	4.61	0.63	8.37	2.93	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.41	5.08	0.39	6.45	2.34	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	52.97	4.43	1.27	12.87	3.80	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	50.31	5.77	1.15	9.90	2.64	6.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	66.57	3.93	1.31	8.04	2.43	4.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	72.63	4.60	0.19	5.56	1.15	3.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	60.29	5.31	1.23	7.36	2.04	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	54.00	3.63	0.20	4.43	2.01	3.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.10	5.40	0.00	8.10	4.59	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	46.81	4.56	0.24	4.80	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	50.58	4.71	0.94	4.47	1.41	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	46.41	3.51	0.59	5.42	1.46	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	42.39	4.01	0.63	2.95	1.69	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	41.96	4.02	0.87	4.02	0.87	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	36.14	3.21	0.80	3.41	1.20	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.85	3.95	0.47	4.19	0.70	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	26.39	2.88	0.24	3.84	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.33	5.07	0.30	3.58	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	30.16	3.11	0.24	1.91	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.16	4.45	0.81	2.63	0.61	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	24.59	3.28	0.20	3.48	1.23	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	32.24	4.67	0.89	4.00	1.33	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	39.03	1.06	0.00	2.13	1.77	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.49	2.65	1.33	1.66	0.33	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	49.50	2.52	0.00	11.75	1.68	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.45	1.38	0.92	4.13	0.46	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	36.62	1.94	0.32	1.94	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.76	1.93	0.96	0.32	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.80	0.94	0.63	5.03	0.31	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	28.20	4.23	0.71	2.82	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	23.55	2.24	1.12	1.68	1.12	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	34.23	2.39	1.59	4.78	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	17.33	2.04	0.68	2.72	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.52	2.60	0.32	2.92	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	22.36	1.42	1.06	1.77	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	0.00	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	0.00	0.00	15.79	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	13.16	3.90	0.98	1.46	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	1.98	0.99	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	0.94	0.00	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.57	2.32	0.33	1.66	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	13.61	4.02	0.31	0.93	0.31	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.59	3.97	0.31	0.00	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	14.10	3.64	0.00	0.48	0.16	1.11
Adipocyte - breast, donor2	11327-117E4	22.14	2.41	0.00	1.44	2.41	3.37
Adipocyte - omental, donor1	11473-119C6	25.83	4.07	0.51	0.89	0.64	1.15
Adipocyte - omental, donor2	11474-119C7	22.42	0.75	0.00	0.00	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	24.11	2.34	0.33	0.67	0.67	1.67
Adipocyte - perirenal, donor1	11476-119C9	9.57	1.91	0.00	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.39	0.45	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	21.55	1.04	0.35	0.17	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	57.89	5.08	0.39	0.39	0.39	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	30.37	2.32	1.03	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	43.49	3.62	0.28	0.56	0.00	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	37.03	4.70	0.59	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	42.15	2.73	0.40	0.16	0.24	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	28.73	1.29	0.32	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	32.52	0.53	0.00	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	0.56	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	21.21	0.42	0.83	0.42	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	15.82	0.50	0.00	0.25	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	16.36	0.65	0.33	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	20.10	0.30	0.00	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	33.81	5.75	0.22	0.66	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	81.76	5.74	1.43	1.08	1.08	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	2.40	0.00	1.20	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	22.49	1.62	0.54	0.36	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	1.67	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	31.23	1.64	0.62	0.82	1.03	0.41
Anulus Pulposus Cell, donor1	11248-116E6	13.50	1.03	0.11	0.80	0.23	0.34
Anulus Pulposus Cell, donor2	11463-119B5	31.35	1.22	0.00	0.24	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.13	0.00	0.90	1.35	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.72	0.87	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	0.60	0.00	0.90	0.30	1.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	0.00	0.00	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.47	0.97	0.65	0.32	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	9.71	0.49	0.97	0.00	1.46	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.38	1.19	0.59	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.79	0.75	0.38	0.38	0.00	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	2.18	0.00	2.90	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.25	1.81	0.16	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	4.67	1.51	0.15	0.15	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.32	1.61	0.00	0.00	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.74	0.00	0.19	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.68	2.14	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.61	1.33	0.17	0.50	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	0.00	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	3.54	0.00	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.58	0.69	0.00	1.37	0.00	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.14	1.46	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.04	1.90	0.00	1.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	2.42	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.69	0.57	0.00	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	1.28	0.00	1.50	0.21	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.74	1.29	0.26	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	1.41	0.00	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.29	0.64	0.00	0.96	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	1.43	0.71	0.71	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	1.17	0.58	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.84	0.60	0.30	0.30	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	3.56	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	1.02	0.51	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.79	1.53	0.00	1.53	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	4.45	0.64	0.00	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.65	0.43	0.00	0.00	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.64	0.85	0.00	0.42	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	5.51	0.87	0.29	0.00	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	20.78	0.94	0.00	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.22	0.85	0.00	0.68	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	0.00	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	0.00	0.00	0.00	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.44	1.29	0.21	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	2.41	0.60	0.60	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.71	0.92	0.00	0.46	0.46	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.83	1.27	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	12.59	1.03	0.21	0.41	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.65	0.31	0.61	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.91	1.43	0.48	0.48	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.86	1.33	0.00	0.44	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	10.52	0.00	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	0.53	0.00	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.63	0.73	0.00	0.36	1.09	0.36
Astrocyte - cerebellum, donor1	11500-119F6	25.18	1.97	0.49	0.25	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	32.35	0.68	0.51	0.51	0.34	0.34
Astrocyte - cerebellum, donor3	11661-122F5	20.97	1.68	1.05	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	13.59	0.70	0.00	1.74	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	24.10	2.10	0.00	1.29	0.32	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	21.18	0.89	0.00	0.00	0.75	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	6.88	0.00	1.83	0.92	0.34	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	7.77	0.00	1.38	0.25	0.25	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	5.80	0.00	0.91	0.23	0.34	0.00
Basophils, donor1	12241-129G9	42.11	0.00	3.40	0.00	0.00	0.26
Basophils, donor2	12242-129H1	120.14	0.00	5.41	0.36	0.00	0.72
Basophils, donor3	12243-129H2	37.93	0.00	1.76	0.44	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	25.44	1.08	0.43	0.86	1.29	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	65.83	0.46	0.00	0.91	0.46	2.74
Bronchial Epithelial Cell, donor3	11672-122G7	64.56	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	50.84	0.00	0.00	0.00	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	61.35	1.46	1.04	0.42	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	51.12	1.38	0.23	0.23	0.46	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	29.33	0.36	0.72	0.72	0.36	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	6.18	0.00	1.75	0.00	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	6.06	0.00	0.93	0.00	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	4.16	0.00	0.96	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	18.60	0.56	5.07	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	33.59	0.00	3.53	0.93	1.86	0.74
CD14+ Monocytes, donor3	11381-118B4	36.00	0.44	2.41	0.22	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.94	0.00	0.57	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	13.65	0.00	0.38	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	9.86	0.00	2.63	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	15.90	0.00	0.72	0.14	0.29	1.73
CD14+ monocytes - mock treated, donor2	11873-125C1	13.88	0.00	0.91	0.60	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	29.37	0.00	0.95	1.18	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	9.37	0.00	0.67	0.50	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.28	0.00	1.10	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	11.65	0.00	0.50	0.00	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.52	0.00	0.39	0.00	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.74	0.00	0.53	0.36	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.92	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.38	0.00	0.70	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	15.31	0.00	0.00	0.00	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.73	0.00	0.59	1.19	0.30	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.97	0.00	0.60	0.40	0.60	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.87	0.00	0.00	0.62	0.00	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.92	0.00	0.69	0.00	0.69	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	8.82	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	11.35	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.15	0.00	0.27	0.54	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	5.41	0.00	0.70	0.17	0.17	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	0.00	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.82	0.00	0.18	1.29	0.18	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.39	0.00	1.06	0.35	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	19.30	0.00	0.00	0.00	0.00	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.71	0.00	0.87	0.00	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.58	0.37	1.49	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.17	0.00	0.65	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	0.41	0.00	0.41	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.65	0.00	0.70	0.23	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	8.12	0.00	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	0.44	0.00	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.08	0.00	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	0.65	0.00	0.87	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	4.98	0.00	1.56	0.16	0.00	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	1.75	0.00	2.10	0.00	0.00	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	4.24	0.00	4.24	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	2.04	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.88	0.00	0.22	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	0.00	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	0.00	1.04	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	12.26	0.00	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	11.79	0.00	0.54	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	12.63	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	11.77	0.00	1.57	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	15.82	0.00	1.32	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	31.23	0.00	4.11	0.82	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	26.12	0.00	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	42.41	0.00	3.03	1.01	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.40	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.40	0.00	0.80	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	8.03	0.00	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	46.63	0.00	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2.25	0.00	1.50	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	4.28	0.00	1.13	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	149.96	0.00	5.00	1.43	1.79	2.50
CD4+ T Cells, donor2	11306-117C1	193.51	0.00	1.22	9.19	7.35	1.84
CD4+ T Cells, donor3	11382-118B5	181.47	0.00	6.40	3.35	2.74	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	42.37	0.00	4.59	0.51	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	39.53	0.00	2.92	0.67	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.97	0.00	3.16	0.57	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	105.72	0.00	3.79	1.90	0.00	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	103.94	0.00	0.70	0.70	1.40	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	102.18	0.00	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	18.64	0.00	1.59	0.29	0.29	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	16.78	0.00	3.56	0.34	0.34	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	17.09	0.00	1.61	0.64	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	53.35	0.00	0.45	0.90	0.00	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.88	0.00	1.05	1.05	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	58.96	0.00	2.64	1.76	0.44	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	0.00	2.53	0.84	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.53	0.00	0.83	0.83	0.83	1.87
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.04	0.00	2.34	0.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	123.19	0.54	3.54	2.72	1.36	5.17
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	116.84	2.14	4.29	0.00	0.00	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	0.00	3.59	1.79	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	38.20	0.00	1.67	0.93	0.56	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.69	0.00	2.38	0.22	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.46	0.00	2.31	0.42	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	95.05	0.00	0.51	0.51	0.51	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	68.02	0.00	2.17	0.00	0.00	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	88.03	0.44	2.18	2.61	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	87.10	0.00	3.46	1.48	0.49	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	63.70	0.00	0.92	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	65.60	1.40	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	110.77	0.55	4.43	0.55	0.00	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	119.26	0.00	2.45	0.74	0.98	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	0.00	6.16	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	77.35	0.36	2.15	0.72	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	91.41	0.00	1.38	0.00	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	193.82	0.00	4.91	1.96	0.33	1.96
CD8+ T Cells, donor2	11307-117C2	220.75	0.00	3.00	7.51	4.13	3.38
CD8+ T Cells, donor3	11383-118B6	229.01	0.25	5.05	3.79	3.28	3.03
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.00	0.00	0.00	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.48	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.55	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	0.90	0.00	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1.20	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.45	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.09	0.00	0.22	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	0.26	0.00	0.26	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.64	0.00	0.00	0.00	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1.21	0.00	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	0.00	0.00	0.58	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	0.27	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	0.00	0.44	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.10	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.36	0.00	0.36	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	1.73	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.71	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.58	0.00	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1.54	0.00	0.00	0.00	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.29	0.00	0.38	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1.18	0.00	0.39	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	6.42	0.00	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	5.60	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	0.00	1.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	69.45	0.00	0.00	14.62	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	12.85	0.49	0.49	1.48	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	16.10	1.68	0.21	0.32	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	13.52	0.69	0.00	1.39	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	22.74	0.71	0.36	0.36	0.36	1.42
Chondrocyte - de diff, donor3	11410-118E6	19.68	0.80	0.11	1.25	0.80	0.68
Chondrocyte - re diff, donor2	11339-117F7	27.75	0.00	0.90	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	22.24	2.43	0.00	0.40	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	15.15	1.61	0.34	0.46	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	16.03	2.57	0.21	0.43	0.21	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	18.85	1.68	0.35	0.44	0.35	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	24.12	1.01	1.83	0.46	0.55	0.09
Corneal Epithelial Cells, donor1	11526-119I5	50.50	1.54	0.66	1.10	1.54	0.22
Corneal Epithelial Cells, donor2	11606-120I4	30.72	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	36.30	0.51	0.77	0.51	1.28	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	1.32	0.00	0.66	0.17	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.00	0.00	0.32	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.38	0.00	0.86	0.00	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	13.32	0.00	2.39	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	12.40	0.00	1.96	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.65	0.00	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	11.17	1.00	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	0.00	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	15.55	0.85	1.41	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	10.62	0.00	1.18	0.00	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.14	0.29	0.29	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	10.82	2.12	0.24	0.71	0.47	1.88
Endothelial Cells - Artery, donor3	11413-118E9	17.71	1.05	0.00	0.35	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	7.09	0.00	0.00	0.00	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	7.30	0.61	0.61	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	8.18	0.00	1.13	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	6.24	0.30	0.59	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	0.00	1.04	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	9.36	0.14	0.57	0.43	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	6.00	0.00	0.00	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	7.34	2.10	0.00	0.52	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	10.69	0.37	1.12	0.00	0.25	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.56	0.43	1.30	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.27	0.37	1.22	0.12	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	19.34	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	9.42	0.47	0.47	0.00	0.00	0.31
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	79.21	0.00	4.95	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	64.20	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	33.96	1.22	0.98	0.49	0.98	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	56.16	4.16	0.00	0.00	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.35	2.87	0.82	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.38	0.33	0.00	1.09	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.34	1.95	0.22	2.82	0.33	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.55	2.06	0.49	0.85	0.73	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.20	1.91	0.41	0.27	0.41	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.79	2.32	0.11	1.27	0.95	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.51	1.05	0.53	0.79	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	24.25	4.32	0.00	0.33	2.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	31.30	1.81	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	30.32	2.27	1.52	0.76	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	29.34	3.31	0.32	1.26	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	29.70	2.73	0.30	0.30	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	21.95	2.16	0.38	0.38	0.38	0.76
Fibroblast - Cardiac, donor6	11460-119B2	18.19	0.45	0.30	0.45	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	32.96	1.61	0.27	0.94	0.94	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.83	0.86	0.86	3.45	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	0.00	0.00	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	28.37	1.38	0.69	0.00	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	20.01	0.00	0.00	1.53	0.85	0.34
Fibroblast - Dermal, donor1	11269-116G9	13.38	1.64	0.23	0.47	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	11.79	1.42	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.76	1.69	0.48	0.00	0.36	0.12
Fibroblast - Dermal, donor4	11450-119A1	12.77	0.34	0.23	0.34	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	15.18	1.74	0.52	0.17	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	20.79	1.30	0.65	0.32	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	19.57	1.25	0.21	0.00	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.82	3.93	0.26	0.52	0.52	0.79
Fibroblast - Gingival, donor2	11318-117D4	22.80	1.58	0.53	0.92	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	46.22	2.22	0.39	0.68	0.87	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	24.93	7.27	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.30	2.82	0.35	1.41	0.88	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	30.09	3.27	0.16	0.78	0.31	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.39	2.16	0.27	0.68	0.54	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	45.52	3.18	1.41	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	19.01	2.63	0.29	0.73	0.44	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.77	1.77	0.55	1.09	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	23.91	2.08	0.22	0.66	0.44	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	44.61	3.08	0.29	1.17	0.44	0.29
Fibroblast - Lung, donor1	11270-116H1	31.27	4.08	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	1.49	0.00	1.49	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	16.25	1.48	0.00	0.42	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	57.48	2.50	5.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	0.00	0.00	0.00	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	22.39	1.68	0.56	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	42.63	2.84	1.62	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	13.19	1.16	0.58	0.39	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.85	1.21	0.15	0.91	0.76	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.76	2.45	0.31	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.40	1.91	1.14	0.38	0.76	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.38	2.16	0.27	0.54	0.00	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.78	3.60	0.35	0.46	0.00	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	7.96	1.77	0.11	0.11	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.42	5.69	0.41	1.02	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	1.34	0.00	0.00	0.67	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.02	0.40	0.00	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	44.65	1.98	0.00	1.98	1.79	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.52	1.95	0.18	0.36	0.53	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	24.44	2.56	0.20	2.37	1.38	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	26.78	1.81	0.60	0.90	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	28.28	2.81	0.43	0.97	0.76	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	42.26	0.76	0.76	0.51	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	22.15	2.79	0.49	1.31	1.48	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.70	4.01	0.20	1.00	0.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	34.86	2.61	0.90	0.80	0.40	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	52.89	1.21	0.30	1.81	1.21	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.94	4.14	0.33	0.58	0.75	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.18	0.34	0.00	0.85	0.68	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	44.34	0.99	0.33	0.99	0.66	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.94	1.60	0.85	1.28	0.96	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	20.92	2.19	0.17	1.69	1.01	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	19.76	0.78	0.16	4.39	0.78	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00	88.64	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.44	0.69	0.87	0.00	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	39.56	1.04	1.04	1.04	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	47.53	1.53	1.02	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	10.72	5.36	0.77	1.53	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.74	7.66	0.00	0.64	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	16.55	5.99	0.29	0.86	0.29	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	20.68	5.52	0.00	0.00	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	14.38	2.28	0.68	0.46	0.00	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	13.08	9.71	0.20	1.19	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	17.45	3.97	0.53	2.11	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.22	2.61	1.63	0.33	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.48	10.61	0.44	0.44	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.84	6.22	0.28	1.13	0.71	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.51	5.17	0.37	1.60	0.99	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.43	6.45	1.07	0.81	1.07	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.47	6.69	0.37	1.12	0.12	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.27	6.23	0.14	1.80	1.11	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	19.52	7.93	0.41	1.22	0.81	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.17	4.34	0.91	1.37	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.67	3.61	0.25	0.50	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	23.17	7.65	0.44	1.31	0.66	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.07	2.66	0.00	0.89	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	16.53	3.97	0.32	0.95	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	19.66	4.24	0.67	0.89	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	14.72	1.21	1.01	0.60	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.38	1.87	0.17	1.87	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.31	6.21	0.44	0.89	0.18	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	19.67	4.16	0.83	0.42	0.83	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.03	3.59	1.02	0.51	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.38	1.77	0.44	0.55	0.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	11.15	4.66	0.50	0.50	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.82	5.31	0.41	0.20	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	14.65	1.86	0.21	1.03	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	15.80	1.96	0.35	1.04	0.58	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.84	1.83	0.50	0.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	17.63	1.32	0.00	0.66	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	16.11	0.98	0.12	1.11	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.13	0.65	0.32	0.65	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.96	1.28	0.96	0.32	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.11	1.23	0.19	0.66	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.87	0.95	0.32	0.47	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.68	1.52	0.30	0.91	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.75	1.67	0.42	0.73	0.84	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.03	0.88	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.67	0.28	0.84	1.12	0.28	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.30	1.30	0.37	0.93	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	12.03	1.34	0.27	0.80	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.01	1.38	0.46	0.46	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.34	0.91	0.26	0.52	0.39	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.45	1.36	0.27	0.27	1.08	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.47	1.29	0.74	0.92	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	26.76	1.10	0.44	0.44	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	5.95	0.00	1.98	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.70	1.19	0.13	1.06	0.40	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	28.25	1.01	0.61	1.01	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.43	3.81	1.02	2.54	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	18.71	7.17	0.00	1.39	0.60	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	19.41	9.09	0.77	1.85	0.77	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	20.87	6.34	0.00	0.61	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.95	4.38	0.00	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	4.24	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	13.37	5.53	0.92	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	12.37	0.00	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.86	5.42	0.77	0.39	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	9.63	4.81	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	1.74	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	11.39	5.53	0.00	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.77	3.29	0.82	2.88	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.11	4.19	0.00	0.56	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.15	5.88	0.00	1.31	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.94	4.19	0.00	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.40	6.68	0.00	0.64	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	11.21	5.43	0.00	0.34	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	6.26	8.35	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.74	8.02	0.00	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.66	6.51	0.30	0.30	0.89	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.81	4.56	0.83	0.41	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.51	5.29	0.46	0.23	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.30	4.23	0.00	1.15	0.38	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	10.76	5.22	0.00	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	11.37	3.34	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.18	6.55	0.77	1.16	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.83	11.64	0.00	2.05	1.03	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	9.94	4.97	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	14.63	6.61	0.00	1.42	0.94	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	17.50	3.02	0.00	0.60	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	11.70	4.58	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.16	5.98	0.00	0.40	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.83	4.93	0.49	0.99	0.99	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	20.07	4.72	0.00	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.67	7.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	14.48	4.39	0.44	1.76	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	18.65	8.48	0.00	4.24	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.92	4.78	0.00	2.98	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	2.43	0.00	0.49	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	76.47	1.14	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	49.90	1.66	2.08	1.25	1.66	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	6.75	1.12	1.12	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.54	1.59	0.32	0.32	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.47	0.42	0.00	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.76	2.55	1.04	0.81	0.58	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.83	2.87	0.51	1.18	0.68	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	10.47	2.05	0.00	1.14	0.91	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.54	1.64	0.44	0.55	0.44	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.75	2.15	0.43	1.07	0.86	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.27	2.80	0.43	0.86	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.46	0.75	0.00	0.75	0.37	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	7.55	1.20	0.51	0.51	0.17	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	6.09	0.64	0.00	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	0.00	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	26.83	2.16	0.00	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	38.45	3.53	0.35	0.00	1.06	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	1.45	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.66	1.05	0.17	1.57	0.87	0.00
Hepatocyte, donor1	11523-119I2	12.11	0.00	0.00	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	11.85	0.00	0.00	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	14.72	0.00	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.18	0.00	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	56.98	15.38	1.05	2.62	2.45	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.98	1.10	0.55	0.82	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	15.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	2.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	1.67	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	0.00	1.32	0.00	2.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.78	0.00	0.63	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.17	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.96	0.00	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	0.00	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	10.45	0.00	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	6.35	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	0.00	2.15	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	11.43	0.00	2.54	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	10.20	0.00	0.00	1.28	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	0.00	3.65	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	0.00	0.71	1.43	1.43	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	0.31	0.62	0.00	0.62	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	15.80	0.00	1.76	1.76	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	0.00	2.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	0.00	0.87	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	8.53	0.00	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	0.00	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	0.00	2.11	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	24.56	1.06	1.06	1.06	1.22	1.06
Keratinocyte - epidermal, donor2	11349-117G8	21.67	1.76	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	30.01	0.66	0.19	1.04	0.57	0.09
Keratinocyte - oral, donor1	11251-116E9	46.43	0.57	0.79	2.27	3.18	1.25
Keratocytes, donor1	11527-119I6	43.32	1.72	1.03	0.69	0.69	0.00
Keratocytes, donor2	11607-120I5	21.09	2.34	1.17	1.17	2.34	0.00
Keratocytes, donor3	11688-122I5	34.97	1.78	0.59	1.78	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	2.20	4.40	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	13.03	0.46	0.35	0.23	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.26	1.31	0.30	0.40	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.92	0.36	0.59	0.47	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.54	0.56	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.07	0.00	0.94	0.16	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	0.00	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.29	0.63	0.63	0.32	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	8.84	0.00	0.22	0.54	0.97	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.31	0.00	0.00	0.41	0.82	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	0.25	0.51	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.25	0.00	0.56	0.42	0.99	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.10	0.00	0.40	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	5.43	0.19	0.39	0.58	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.07	0.00	0.56	0.19	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.76	0.35	0.00	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.20	0.00	0.48	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.48	0.14	0.14	0.96	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.62	0.00	0.00	0.92	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.04	0.00	0.31	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.26	0.00	0.91	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.91	0.00	0.99	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.49	0.59	0.00	0.00	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	10.21	0.00	0.25	0.50	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.36	0.97	0.00	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.81	0.00	0.81	0.00	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.17	0.00	0.15	0.76	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	5.18	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.70	0.63	0.42	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.82	0.00	0.45	0.75	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.77	0.19	0.38	0.56	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.97	0.21	0.42	1.17	0.85	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	0.00	0.48	1.45	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.60	0.00	0.33	0.99	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.04	0.00	0.25	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	0.37	0.74	0.74	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.66	0.00	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.11	0.00	0.82	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.01	0.00	0.64	1.61	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	8.83	0.00	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.54	0.14	0.70	0.42	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.11	0.00	0.71	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.00	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.27	0.00	0.78	0.78	0.16	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.24	0.00	0.36	0.36	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.76	0.00	0.98	0.33	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.18	0.00	0.47	0.24	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.11	0.25	0.37	0.12	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	5.89	0.26	0.77	0.00	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.04	0.00	1.19	0.60	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	0.00	2.27	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	77.48	3.07	0.00	0.00	1.53	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	41.56	2.97	1.48	1.48	0.74	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	66.01	7.19	2.54	2.54	2.96	4.65
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	75.96	7.03	2.81	5.63	3.52	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	44.83	1.87	1.87	5.60	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	39.16	9.79	3.61	6.70	3.61	5.67
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	67.80	2.38	1.19	3.57	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	51.80	5.43	2.04	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.28	1.45	2.04	3.20	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.97	4.05	1.80	2.70	0.90	3.15
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	68.42	8.26	4.74	2.03	0.68	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	48.78	5.14	3.08	5.14	2.57	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	56.81	1.41	3.18	3.53	1.76	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	40.64	4.66	2.00	2.67	2.00	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.67	2.55	3.06	5.09	5.09	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	64.83	3.74	1.87	2.93	2.13	2.93
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	63.67	3.97	1.13	3.78	2.27	3.40
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	5.52	4.29	3.68	2.45	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	105.19	4.89	1.63	3.26	4.89	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	66.64	3.54	1.25	6.87	3.12	3.54
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	39.52	5.04	1.96	3.92	2.80	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	88.61	3.09	2.06	5.15	3.09	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	67.64	3.48	2.03	10.45	3.77	5.23
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	33.18	2.69	1.79	3.89	1.49	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	58.65	3.32	1.11	4.98	2.21	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	114.53	6.72	2.83	7.07	3.89	5.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	59.00	4.43	2.95	3.69	2.58	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	80.59	5.76	5.76	1.15	1.15	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	92.10	4.61	3.45	4.99	2.69	3.84
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	50.95	6.79	3.96	8.49	5.10	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	66.46	1.64	2.46	3.28	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	96.25	4.07	4.52	2.26	6.33	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	53.14	2.87	3.59	2.15	1.44	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	90.38	5.98	6.72	3.73	4.48	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	95.87	6.32	2.97	6.32	5.95	9.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	32.74	3.88	1.72	1.72	0.86	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	74.50	4.28	4.28	0.00	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	81.30	3.33	3.00	5.00	2.33	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	52.49	4.22	3.62	4.83	1.21	5.43
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	75.37	2.84	2.84	2.84	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	75.27	7.22	2.75	6.53	5.16	4.47
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.04	2.68	2.68	6.44	4.83	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	79.46	0.67	3.37	0.67	1.35	4.04
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	88.53	6.67	3.33	5.19	5.56	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	62.80	3.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	61.35	3.17	5.29	4.23	2.12	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	94.04	4.40	4.40	7.20	2.00	6.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	66.15	7.27	0.00	0.73	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	101.95	4.60	4.60	1.53	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	85.34	6.91	1.48	8.39	4.93	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	72.45	4.70	0.00	6.59	3.76	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	113.64	6.54	2.51	2.51	2.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	96.43	7.21	3.60	6.31	4.06	6.76
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	46.47	5.16	0.00	5.16	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	106.44	4.90	5.34	6.23	2.67	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	110.66	5.87	2.74	5.47	6.26	5.47
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	6.60	2.64	3.96	1.98	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	118.32	6.23	3.11	4.15	2.08	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	135.65	7.44	4.38	9.63	8.75	7.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	73.80	7.27	3.35	4.47	1.68	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	121.45	6.18	4.42	3.97	1.77	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	102.21	5.01	5.79	4.24	3.47	5.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	70.38	4.56	4.56	2.03	5.57	7.60
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	116.79	3.36	2.88	5.29	1.92	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	112.51	7.55	3.98	5.17	3.98	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	80.21	4.25	4.86	10.94	6.08	5.47
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	80.24	1.38	0.00	5.53	2.08	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	112.48	6.46	2.66	7.98	5.32	7.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	96.57	10.33	1.55	9.30	5.68	10.33
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	131.21	6.05	1.21	5.44	4.23	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	125.18	5.70	3.80	10.77	6.02	8.24
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	104.49	10.66	3.20	5.33	4.80	5.33
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	105.74	4.02	4.02	3.45	3.45	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	163.53	7.71	4.63	14.40	7.20	9.77
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	87.00	7.07	4.95	6.37	4.95	7.07
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	116.90	6.81	2.27	6.81	2.27	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	135.21	3.33	4.16	6.24	5.82	4.99
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	65.78	4.70	7.83	7.05	4.70	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	98.96	4.18	5.01	5.43	3.34	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	116.62	6.97	3.72	4.65	4.65	7.43
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	64.23	3.35	3.35	6.02	2.01	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	105.32	2.14	1.07	4.81	3.21	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	122.85	3.64	2.42	8.49	8.08	9.29
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	64.24	4.59	4.59	5.51	4.59	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	93.36	5.33	4.45	1.78	6.22	6.22
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	120.81	5.70	2.85	2.85	1.14	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	57.52	6.90	5.37	10.74	2.30	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.94	1.64	3.28	4.38	2.74	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	126.95	3.56	5.79	5.79	3.56	6.24
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	74.87	10.14	5.46	1.30	1.04	2.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	76.26	5.30	5.97	3.32	2.65	3.98
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	108.09	2.08	10.39	8.31	4.16	8.31
Macrophage - monocyte derived, donor1	11232-116C8	4.56	0.00	1.14	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	2.94	0.00	0.55	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	9.31	0.00	0.92	0.00	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.62	1.59	1.06	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	18.06	1.58	0.32	0.00	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	18.21	1.11	0.83	0.28	0.56	0.56
Mammary Epithelial Cell, donor1	11273-116H4	28.50	2.79	1.00	1.40	0.70	0.40
Mammary Epithelial Cell, donor2	11350-117G9	27.51	1.16	1.16	1.16	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	31.68	1.00	0.75	0.50	0.25	0.75
Mast cell - stimulated, donor1	11487-119E2	5.42	0.00	1.36	2.03	2.03	0.00
Mast cell, donor1	11563-120D6	7.89	0.00	2.38	0.11	0.32	0.54
Mast cell, donor2	11565-120D8	18.72	0.00	3.86	0.30	0.00	0.30
Mast cell, donor3	11566-120D9	24.99	0.00	13.06	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	19.86	0.18	5.32	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	5.10	0.00	1.89	0.22	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	9.92	0.00	4.67	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	2.64	0.00	1.72	0.23	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	12.89	0.00	3.35	0.67	0.00	0.33
Melanocyte - dark, donor1	11502-119F8	6.17	0.10	0.10	0.00	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	18.34	1.04	0.35	1.04	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	8.62	0.87	0.58	0.22	0.14	0.07
Melanocyte - light, donor1	11274-116H5	13.40	1.18	0.94	0.00	0.71	0.24
Melanocyte - light, donor2	11351-117H1	10.24	2.73	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	18.21	1.73	2.60	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.64	1.25	0.31	0.21	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	8.88	0.27	0.00	0.00	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	8.57	0.27	0.27	0.27	0.00	0.27
Meningeal Cells, donor1	11493-119E8	38.95	1.98	0.87	0.99	0.74	0.25
Meningeal Cells, donor2	11573-120E7	35.21	0.00	0.44	0.00	0.00	0.88
Meningeal Cells, donor3	11654-122E7	14.83	1.39	0.49	0.98	0.57	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	8.55	1.14	0.29	1.43	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.67	3.22	0.10	0.20	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	77.54	9.20	0.00	0.00	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	32.70	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.07	3.59	1.44	2.15	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.82	1.06	0.21	0.85	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.58	0.00	0.00	1.51	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.47	1.32	1.10	0.44	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	3.65	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	22.10	2.66	0.41	0.61	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	16.07	0.55	0.00	0.55	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	34.94	2.60	0.37	0.00	0.37	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.08	1.58	0.13	1.71	0.66	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.69	1.48	0.00	1.19	1.19	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	33.94	1.92	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	13.11	1.42	0.71	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	2.19	0.00	0.00	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	16.69	1.45	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	25.46	2.39	0.27	0.53	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	21.02	2.00	1.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	32.45	3.90	0.51	0.79	1.59	1.01
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	10.80	0.00	6.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	4.19	0.00	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.01	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	1.86	0.00	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.11	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	3.50	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	2.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.45	0.00	0.61	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	4.36	0.40	1.19	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	1.77	0.00	0.00	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.42	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	1.49	0.00	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.49	0.00	0.89	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1.76	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	6.65	0.00	0.48	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.78	0.00	0.42	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.11	0.00	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.22	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.11	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.53	0.00	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.23	0.00	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	0.00	0.80	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.50	0.00	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	1.75	0.00	0.44	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	0.00	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.73	0.00	0.25	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	6.15	0.00	1.03	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.94	0.00	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	0.00	2.49	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.33	0.00	0.84	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	0.00	1.25	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	0.00	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.83	0.00	0.90	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.01	0.00	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	0.00	1.85	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	5.12	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.57	0.00	1.11	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	4.15	0.00	0.52	0.26	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.01	0.00	1.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.80	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	0.00	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.87	0.00	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.17	0.00	0.28	0.42	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	4.14	0.00	0.96	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	7.52	0.00	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.17	0.00	1.14	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.24	0.00	1.70	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	0.00	0.98	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	0.00	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.82	0.00	2.94	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.03	0.00	1.44	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	0.00	3.30	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	0.00	1.79	0.00	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	4.93	0.00	0.99	0.66	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	1.98	0.00	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	1.13	0.00	0.11	0.00	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	2.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	0.00	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.11	1.08	0.22	1.72	0.43	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.74	1.05	0.00	2.09	1.05	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	3.34	5.34	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.86	4.17	0.00	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	13.69	1.52	0.19	0.00	0.19	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	17.55	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	2.72	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	5.51	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.97	2.09	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	17.20	3.02	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.59	1.35	0.00	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.18	1.68	0.42	0.84	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	1.99	0.00	0.99	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.83	1.35	0.54	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.65	1.81	0.23	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.10	2.78	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.77	1.28	0.55	0.36	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.37	0.53	0.00	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	16.21	0.60	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.80	1.31	0.00	1.64	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.68	2.11	0.00	0.16	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.69	1.59	0.88	0.18	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	2.81	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	23.45	3.22	0.00	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.10	0.96	0.32	0.00	0.32	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	26.90	0.34	0.34	2.41	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	93.55	2.53	0.00	7.59	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.06	1.34	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	10.58	3.39	0.00	1.27	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.70	2.14	0.00	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.31	3.00	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	153.47	0.00	0.00	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.33	1.00	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	25.25	3.61	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	2.38	0.40	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	0.93	0.00	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	18.16	0.38	0.00	1.14	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.36	3.26	0.00	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.69	2.61	0.00	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	30.76	2.26	0.45	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	0.88	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.42	0.99	0.00	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.25	1.53	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	27.83	1.21	0.30	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.12	1.55	0.00	0.22	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	1.36	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	1.83	0.00	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.00	3.15	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.00	3.03	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	1.58	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	3.40	0.00	3.40	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	9.81	1.12	0.62	0.12	0.75	0.25
Myoblast, donor2	11322-117D8	22.63	1.34	0.77	0.77	0.58	0.58
Myoblast, donor3	11398-118D3	13.12	1.85	0.34	0.00	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	12.55	0.00	0.73	0.29	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	139.00	0.00	3.38	1.85	3.08	0.92
Natural Killer Cells, donor2	11311-117C6	182.74	0.00	2.71	4.82	3.02	1.81
Natural Killer Cells, donor3	11387-118C1	152.95	0.18	3.50	3.87	2.58	2.02
Neural stem cells, donor1	11275-116H6	18.51	1.45	0.73	1.09	0.73	0.36
Neural stem cells, donor2	11352-117H2	21.18	1.93	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	18.21	0.00	0.00	1.14	0.00	1.14
Neurons, donor2	11574-120E8	15.19	0.44	0.66	0.22	0.66	0.00
Neurons, donor3	11655-122E8	23.84	1.64	0.00	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	12.06	0.00	6.50	0.93	1.86	0.93
Neutrophils, donor2	11314-117C9	20.29	0.00	0.00	0.00	0.00	5.80
Neutrophils, donor3	11390-118C4	17.71	0.00	2.44	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	32.18	1.31	0.12	0.71	1.07	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	31.26	1.30	0.00	1.30	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	16.04	0.80	0.00	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	31.11	0.96	0.28	1.93	0.96	0.55
Olfactory epithelial cells, donor2	11934-125I8	26.92	1.59	0.29	1.59	2.03	1.59
Olfactory epithelial cells, donor3	11935-125I9	18.50	1.59	0.11	1.02	0.57	0.91
Olfactory epithelial cells, donor4	11936-126A1	31.26	4.48	0.19	1.75	0.68	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	36.11	4.81	0.00	1.20	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	18.93	2.13	0.00	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	12.57	2.29	0.00	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	21.72	1.24	0.00	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	18.37	3.32	0.59	0.20	0.00	0.39
Osteoblast, donor2	11354-117H4	13.34	3.51	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	23.46	3.73	0.36	0.00	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	23.67	1.26	0.51	0.34	0.76	0.42
Pericytes, donor1	11491-119E6	35.94	0.89	0.78	0.67	0.89	0.22
Pericytes, donor2	11571-120E5	31.69	1.81	0.45	1.58	1.13	0.91
Pericytes, donor3	11652-122E5	25.84	2.85	0.81	0.81	1.02	0.20
Perineurial Cells, donor1	11499-119F5	14.92	1.36	0.45	0.79	0.11	0.00
Perineurial Cells, donor2	11579-120F4	21.99	1.38	0.18	0.09	0.83	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	68.53	0.00	2.23	2.55	1.91	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	55.34	0.00	2.45	1.47	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	127.22	0.00	3.49	1.42	1.81	1.04
Placental Epithelial Cells, donor1	11278-116H9	26.31	2.39	0.48	0.00	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	19.96	2.22	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	23.95	1.18	0.00	0.20	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	1.90	0.63	2.85	0.63	1.58
Preadipocyte - breast, donor1	11467-119B9	17.82	2.44	0.00	0.94	0.56	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.20	2.35	0.13	0.00	0.26	0.52
Preadipocyte - breast, donor2	11328-117E5	29.72	2.70	0.90	0.68	1.58	2.70
Preadipocyte - omental, donor1	11468-119C1	14.60	3.84	0.00	0.85	0.64	0.21
Preadipocyte - omental, donor2	11329-117E6	22.26	1.75	0.00	0.87	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	25.50	4.87	0.43	2.44	1.15	0.29
Preadipocyte - perirenal, donor1	11469-119C2	25.59	1.97	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	18.73	7.06	0.61	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	17.53	3.19	0.53	1.24	1.06	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	13.11	4.43	0.17	0.51	0.17	0.51
Preadipocyte - visceral, donor1	11280-116I2	10.99	3.54	0.28	0.47	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	11.96	3.22	0.00	0.00	0.46	1.84
Preadipocyte - visceral, donor3	11429-118G7	10.55	1.67	0.10	0.63	0.31	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	40.73	8.45	0.60	1.66	1.06	1.06
Prostate Epithelial Cells, donor2	11331-117E8	29.79	1.22	0.14	1.22	1.08	1.35
Prostate Epithelial Cells, donor3	11404-118D9	45.56	2.94	0.86	3.31	3.43	1.22
Prostate Stromal Cells, donor1	11254-116F3	11.39	2.05	0.00	1.03	0.68	0.23
Prostate Stromal Cells, donor2	11332-117E9	20.08	1.79	0.00	1.08	1.43	0.36
Prostate Stromal Cells, donor3	11405-118E1	22.63	2.40	0.83	0.83	1.56	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.48	3.65	0.73	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.41	2.70	0.62	0.42	0.21	0.35
Renal Epithelial Cells, donor1	11517-119H5	29.93	4.06	0.51	0.00	2.54	0.00
Renal Epithelial Cells, donor2	11597-120H4	21.34	2.85	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	10.27	2.12	0.64	0.32	0.64	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	0.68	0.00	0.68	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.72	0.13	0.67	0.13	0.40	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	16.65	1.78	0.00	0.89	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.98	2.00	1.33	0.00	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	30.37	2.64	1.32	0.66	0.00	0.66
Renal Mesangial Cells, donor2	11598-120H5	16.30	3.76	1.25	0.63	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	29.41	1.39	1.94	0.55	0.83	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	5.10	1.34	0.27	1.07	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	16.87	1.27	0.00	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	21.98	2.31	1.54	0.58	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.30	1.30	1.04	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.29	2.27	0.57	1.42	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	17.50	3.09	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.04	2.51	0.00	0.75	0.25	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	27.53	1.47	0.53	0.13	0.27	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	3.57	0.00	1.79	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	2.75	0.55	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.64	0.58	3.48	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	14.17	1.69	0.65	0.52	0.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.72	1.49	0.79	0.00	0.40	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	9.37	2.01	0.67	0.22	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	19.97	1.24	1.24	0.62	0.87	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	8.97	1.40	1.17	0.58	0.47	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.02	2.54	0.69	0.00	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	18.89	0.96	0.82	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.40	1.97	0.91	0.76	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.35	1.08	0.90	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.77	1.29	1.00	0.29	0.57	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.45	1.40	0.54	0.64	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.96	1.77	0.89	0.44	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.53	0.76	1.15	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.42	0.65	0.93	0.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	7.33	1.88	0.94	0.56	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	14.86	1.06	0.93	0.53	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	12.56	1.65	0.58	0.39	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.08	2.67	0.76	0.95	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	12.92	1.07	0.32	0.32	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	1.68	0.84	1.40	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.11	2.91	0.85	0.00	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.31	0.73	0.36	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	9.69	3.31	0.74	0.37	0.37	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.54	1.34	0.94	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.85	0.71	0.00	0.00	0.47	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.72	2.18	0.20	0.60	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	9.35	1.64	0.23	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.59	0.83	0.83	0.41	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.41	2.21	1.11	0.66	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.32	1.88	0.21	0.21	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.78	0.67	1.21	0.67	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.18	1.87	0.51	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.46	2.12	0.58	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.96	0.69	0.52	0.86	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.34	0.82	0.41	0.41	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	13.95	1.15	0.33	0.99	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.09	0.85	1.36	0.51	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.28	1.63	1.33	0.74	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	15.99	0.53	0.00	0.53	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	12.44	0.83	0.55	0.69	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	6.67	0.48	0.71	0.24	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	14.11	1.81	0.60	0.20	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	6.59	1.04	0.19	0.57	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	8.04	1.40	1.05	0.70	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.76	0.91	0.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	8.81	0.73	0.86	0.12	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	7.86	1.89	0.73	0.44	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.91	0.61	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	5.73	0.30	1.81	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	6.56	0.45	0.90	0.45	1.13	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.18	2.70	0.90	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.91	1.06	0.94	0.00	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	5.98	1.07	0.43	0.00	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	11.42	1.20	2.40	0.60	0.00	0.60
Schwann Cells, donor1	11498-119F4	40.25	0.75	0.56	0.56	0.19	0.94
Schwann Cells, donor2	11578-120F3	3.40	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.47	1.53	0.22	0.88	0.44	0.44
Sebocyte, donor1	11220-116B5	64.64	2.19	2.74	1.64	0.00	1.64
Sebocyte, donor2	11301-117B5	39.06	1.38	0.92	3.22	1.38	0.92
Sebocyte, donor3	11378-118B1	44.73	2.47	0.21	1.03	1.86	1.44
Sertoli Cells, donor1	11255-116F4	19.88	8.28	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	19.77	0.00	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.40	2.11	0.35	0.62	0.26	0.53
Skeletal Muscle Cells, donor2	11358-117H8	17.35	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	31.77	1.67	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	20.74	0.94	0.79	0.16	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	19.62	1.34	0.00	0.30	0.15	0.15
Skeletal Muscle Cells, donor6	11459-119B1	23.39	1.39	0.46	0.15	0.31	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	29.23	2.27	0.25	1.39	1.13	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.24	0.86	0.57	1.00	0.86	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.56	1.59	0.20	0.40	0.60	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	14.15	1.94	0.42	0.67	0.67	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	1.45	0.00	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.71	1.65	0.14	0.28	0.14	1.10
Skin - palm, donor1	10286-104F7	69.84	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.15	0.43	0.58	1.30	1.01	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	0.00	0.82	2.45	2.45	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.44	0.78	0.78	1.82	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	18.21	1.11	0.56	1.11	1.25	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	43.60	1.13	0.14	0.70	0.42	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.92	2.11	2.96	1.27	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	46.77	1.72	0.90	1.50	1.27	1.05
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.37	1.85	0.93	2.16	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.79	0.89	0.67	1.33	1.56	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.39	4.11	1.76	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.09	4.20	0.44	0.66	1.33	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	20.87	5.12	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.81	4.64	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	24.02	1.00	0.00	2.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.83	2.79	0.67	0.13	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.40	0.89	0.00	1.55	1.11	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.27	0.77	0.26	0.00	0.00	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.98	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	10.63	0.59	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.36	1.99	1.00	0.28	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.54	1.63	0.65	0.49	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	31.97	0.61	0.30	1.83	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.28	4.80	0.00	0.51	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	61.21	12.24	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	27.66	3.81	0.95	0.48	0.48	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	11.06	1.62	0.29	0.00	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.23	1.29	0.22	0.00	0.43	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.32	0.63	0.21	0.84	0.21	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	26.30	4.33	0.31	0.15	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	5.39	1.08	0.00	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.83	2.99	0.30	0.00	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.68	2.39	0.34	0.68	1.37	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.36	1.33	0.16	0.55	0.24	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.56	4.73	0.30	1.31	0.60	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	25.26	3.19	0.23	0.91	1.14	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.72	1.21	0.60	0.60	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.96	2.65	0.26	1.85	0.00	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.85	1.60	0.27	0.67	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.17	2.63	0.38	1.63	2.13	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.44	1.27	0.25	0.00	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	11.61	4.37	0.75	0.00	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	22.51	2.25	0.00	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	87.87	0.00	3.88	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.23	3.26	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	21.71	2.52	0.00	1.01	1.01	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	24.44	3.45	0.00	0.31	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.81	0.59	0.29	0.59	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	24.33	1.50	0.42	0.17	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.83	0.47	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.98	3.74	0.00	0.00	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.22	1.78	0.25	0.51	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.97	1.50	0.00	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	18.45	1.68	0.28	0.70	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.10	1.09	0.17	0.34	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	26.19	3.33	0.48	0.00	0.95	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	17.86	2.94	0.49	0.00	0.24	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	12.81	1.99	0.44	1.10	0.88	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.53	3.22	0.29	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.19	0.97	0.00	1.55	0.39	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.99	1.06	0.00	0.79	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	6.70	0.00	0.00	2.23	1.86	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	11.50	1.44	0.00	0.72	0.00	2.16
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.23	0.28	0.00	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	6.30	0.00	0.00	0.39	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.68	1.27	0.25	2.79	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	11.98	0.80	0.00	2.80	0.80	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	7.11	0.84	0.00	0.84	0.00	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	2.29	0.00	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	19.19	2.86	0.34	1.85	0.84	0.50
Synoviocyte, donor2	11368-117I9	16.59	0.50	0.00	0.67	0.67	0.67
Synoviocyte, donor3	11440-118H9	19.88	1.12	0.45	0.67	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	22.15	2.50	0.00	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	3.96	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	24.31	0.93	0.23	0.00	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	31.04	2.01	0.79	0.36	0.07	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	37.50	1.93	0.77	0.39	0.39	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	37.80	1.15	1.15	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	29.40	1.11	1.48	0.37	0.37	0.25
Urethra, donor2	10319-105A4	32.37	0.00	0.00	3.60	0.00	0.00
Urothelial Cells, donor1	11520-119H8	33.21	1.06	0.53	1.33	1.33	0.53
Urothelial Cells, donor2	11600-120H7	23.63	0.40	0.40	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	28.65	0.23	1.60	0.23	0.23	0.46
Urothelial cells, donor0	11216-116B1	24.07	1.34	0.89	0.89	1.11	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.03	0.89	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	25.73	0.00	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.91	0.00	1.37	0.00	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	29.96	0.34	1.03	1.03	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	20.34	0.58	0.00	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	0.00	2.08	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	24.78	0.00	0.00	1.84	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	33.78	0.00	0.00	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	19.61	1.97	0.25	1.48	1.36	0.37
Wilms' tumor cell line:HFWT	10597-108E3	36.96	0.00	2.64	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	58.66	0.56	3.07	2.23	1.68	0.56
achilles tendon, donor2	10292-104G4	24.80	0.00	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.35	0.25	1.27	0.51	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	3.71	0.00	0.93	0.23	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	8.90	0.36	2.14	0.24	0.47	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	4.08	0.00	0.82	0.27	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	3.65	0.00	1.41	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	3.17	0.00	1.48	0.00	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	9.26	0.00	0.82	0.54	0.54	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1.76	0.00	0.44	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	2.04	0.00	3.27	0.00	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	8.15	0.00	0.78	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.47	0.00	0.92	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	9.76	0.00	0.93	0.70	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.85	0.00	1.55	0.52	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.92	0.00	1.75	0.00	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	2.32	0.00	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	4.11	0.00	2.47	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.84	0.00	1.53	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	2.56	0.00	3.84	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.34	0.00	2.73	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.85	0.00	3.13	0.00	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.90	0.00	0.45	0.00	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	7.67	0.00	0.33	0.33	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	0.00	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	4.14	0.00	3.01	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.80	0.00	1.74	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	16.25	0.00	1.65	0.24	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	20.01	1.24	0.93	0.62	0.31	0.16
adipose, donor1	10184-103D4	36.36	2.93	0.00	1.17	0.00	1.17
adipose, donor2	10185-103D5	11.35	0.81	1.22	0.81	0.00	0.00
adipose, donor3	10186-103D6	12.25	1.63	0.27	0.54	0.27	0.00
adipose, donor4	10187-103D7	25.14	7.80	5.20	1.73	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	13.57	0.95	3.47	0.63	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	47.29	0.00	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.27	0.00	2.13	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.72	7.86	0.00	1.07	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	58.19	7.42	0.00	0.93	0.93	1.16
amniotic membrane cells, donor2	12236-129G4	35.16	3.04	0.34	0.68	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	67.46	9.13	0.59	2.65	0.88	0.59
amygdala - adult, donor10196	10167-103B5	2.37	1.19	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	25.95	0.20	1.01	0.41	0.61	0.00
amygdala, newborn, donor10223	10360-105E9	11.30	1.29	0.65	1.61	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	30.81	4.07	0.89	1.02	0.76	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.88	0.44	0.66	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	21.04	0.00	0.33	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	60.80	2.16	0.98	1.57	0.98	0.20
appendix, adult	10189-103D9	38.42	0.00	2.33	0.39	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	12.04	0.00	2.06	1.03	0.00	0.00
artery, adult	10190-103E1	13.59	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	19.85	8.26	0.87	0.87	0.14	0.14
b cell line:RPMI1788	10427-106D4	5.50	0.00	2.08	0.15	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.59	2.22	0.00	0.00	0.55	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	44.36	9.13	0.60	0.50	0.69	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	52.72	9.21	0.67	1.51	1.67	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	3.91	0.00	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	38.89	1.52	0.54	0.76	0.43	0.11
blood, adult, pool1	10053-101G8	17.72	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	60.80	5.14	1.71	0.86	0.00	0.00
bone marrow, adult	10192-103E3	14.85	1.35	1.35	4.72	2.70	2.02
brain, adult, donor1	10084-102B3	15.38	0.00	2.05	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	10.24	0.00	1.11	0.33	0.11	0.00
brain, fetal, pool1	10085-102B4	61.44	0.00	0.00	8.01	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	96.47	3.63	2.64	2.64	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.31	4.37	0.62	1.00	0.25	0.50
breast, adult, donor1	10080-102A8	37.25	0.00	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	19.06	0.64	1.27	0.25	1.14	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	34.32	4.64	1.55	1.24	1.55	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	12.20	8.98	1.84	2.76	3.22	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	60.04	1.69	0.48	1.45	2.42	0.24
carcinoid cell line:NCI-H1770	10703-109H1	3.29	0.00	0.47	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.49	8.31	1.31	0.11	0.66	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	0.63	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.63	0.53	0.27	0.80	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	5.76	0.00	0.00	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.74	0.00	1.84	1.51	1.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	7.64	0.00	0.00	0.76	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	6.96	0.37	1.46	0.73	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	43.70	0.00	2.91	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	111.67	0.00	1.07	1.92	3.42	0.43
cerebellum, adult, pool1	10083-102B2	31.39	0.00	0.34	1.03	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	29.89	0.83	0.83	1.66	0.83	0.83
cerebral meninges, adult	10188-103D8	8.32	0.25	0.25	0.25	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	10.96	0.00	0.00	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	9.49	2.01	0.14	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	37.78	2.15	0.00	0.99	0.50	0.17
cervix, adult, pool1	10013-101C4	62.05	3.36	2.62	1.05	0.52	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.90	0.98	0.56	0.14	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	6.53	1.31	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	28.09	9.07	0.37	1.74	0.99	0.25
choriocarcinoma cell line:SCH	10785-110H2	36.47	13.06	0.37	1.60	1.36	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	55.03	5.46	1.90	0.71	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	39.03	7.98	0.57	1.71	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	41.96	1.49	0.20	0.30	0.10	0.50
chorionic membrane cells, donor3	12240-129G8	60.44	3.30	0.55	3.30	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	4.42	0.19	0.58	0.19	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	6.76	0.00	0.42	0.21	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.85	0.00	1.28	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	4.11	0.00	0.00	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.66	0.00	0.61	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	2.36	0.29	0.29	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.38	0.00	0.52	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.94	3.66	1.83	2.51	2.51	0.69
clear cell carcinoma cell line:TEN	10636-108I6	34.53	7.98	0.69	1.56	0.52	1.39
colon carcinoma cell line:CACO-2	10513-107D9	32.22	20.87	0.73	0.55	1.46	1.10
colon carcinoma cell line:COLO-320	10420-106C6	4.56	0.00	1.14	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	30.94	1.19	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	34.19	0.82	2.35	0.12	0.12	0.47
colon, fetal, donor1	10070-101I7	14.83	0.00	0.62	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	27.50	0.00	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2.55	0.00	1.27	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	2.11	0.00	0.30	0.15	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	2.40	0.00	0.42	0.14	0.00	0.28
corpus callosum, adult, pool1	10042-101F6	16.81	0.11	1.77	0.00	0.44	0.00
cruciate ligament, donor2	10295-104G7	33.23	2.43	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	28.09	0.80	0.80	1.61	0.00	0.00
diencephalon, adult	10193-103E4	8.40	0.00	0.96	0.00	0.48	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	2.53	0.00	1.38	0.23	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.54	5.90	1.28	1.28	0.77	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	8.67	0.24	0.72	0.72	0.72	0.00
ductus deferens, adult	10196-103E7	32.39	0.00	2.49	2.49	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	0.00	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	18.39	0.00	2.94	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	45.51	5.29	4.05	0.58	0.66	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	1.33	0.00	0.22	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	2.44	0.43	0.14	0.14	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	35.76	11.10	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.91	6.36	1.51	0.61	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	27.48	7.10	0.31	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	78.81	7.88	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.81	3.69	0.34	1.01	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	20.84	7.43	2.36	1.45	0.54	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.49	0.64	0.48	0.16	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	29.79	0.33	0.67	0.11	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	23.10	2.75	0.55	0.66	0.55	0.44
epididymis, adult	10197-103E8	26.16	0.63	0.84	1.26	0.42	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.74	7.27	2.66	2.84	1.60	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.11	0.79	0.39	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.17	1.97	1.31	1.57	1.18	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	43.01	2.46	0.98	1.38	1.57	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.61	1.68	0.90	2.24	1.34	0.34
esophagus, adult, pool1	10015-101C6	33.34	0.32	0.64	0.64	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	8.52	0.13	1.13	0.13	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	12.07	0.00	2.41	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	35.72	0.00	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	21.78	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	0.00	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	21.61	0.00	1.02	0.51	0.76	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	14.23	3.59	0.38	0.64	0.51	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.17	5.70	1.90	0.95	0.95	0.47
frontal lobe, adult, pool1	10040-101F4	11.35	0.38	1.78	0.09	0.28	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	65.45	5.10	0.30	4.50	2.70	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	55.23	1.01	0.82	1.28	0.91	0.18
gall bladder, adult	10198-103E9	39.35	2.66	0.48	0.72	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	59.05	0.00	4.83	0.54	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	48.18	0.00	5.23	0.75	0.00	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.36	0.00	0.21	1.06	0.84	2.11
gastric adenocarcinoma cell line:MKN45	10612-108F9	40.62	1.55	1.74	1.74	1.16	0.58
gastric cancer cell line:AZ521	10549-107H9	10.82	5.08	0.82	0.16	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	7.32	20.13	2.75	1.83	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	9.82	0.00	0.91	0.46	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	15.72	3.56	0.57	1.15	0.92	0.69
giant cell carcinoma cell line:Lu99B	10433-106E1	21.69	1.82	1.40	0.56	0.70	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.69	1.25	0.75	1.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.14	3.27	0.32	0.63	0.53	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.70	1.69	0.56	0.14	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	24.06	2.21	1.77	0.33	0.55	0.55
glioma cell line:GI-1	10413-106B8	25.48	3.81	0.00	0.59	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	8.02	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	33.44	0.24	0.98	0.00	0.49	0.24
globus pallidus, adult, donor10258	10367-105F7	9.58	0.00	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	4.80	0.53	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	46.50	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	45.12	0.96	0.00	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	16.07	5.97	1.38	2.75	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	9.15	8.23	0.00	0.91	0.91	0.46
hIPS +CCl2, biol_rep3	14385-156C2	8.37	3.86	0.00	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	8.62	5.75	0.00	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	14.40	3.43	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	9.93	1.10	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.30	0.00	0.86	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	27.80	0.30	0.90	0.90	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	44.19	0.52	1.05	2.88	1.05	0.26
heart - tricuspid valve, adult	10207-103F9	29.14	0.00	0.00	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	41.22	5.71	1.84	2.65	2.86	1.22
heart, adult, diseased, donor1	10051-101G6	39.60	0.43	0.00	2.98	0.85	0.85
heart, adult, pool1	10016-101C7	28.29	1.15	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	47.44	2.26	0.62	0.72	1.44	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.85	1.23	0.00	0.31	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	36.86	5.95	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.54	4.31	0.44	0.66	0.77	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	23.55	4.01	0.49	0.73	0.61	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	24.45	3.94	0.40	1.41	0.91	0.30
hepatoma cell line:Li-7	10484-107A7	20.24	6.23	0.33	0.67	1.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.42	0.00	0.90	0.00	0.00	0.20
hippocampus - adult, donor10196	10169-103B7	5.68	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	26.33	0.20	1.22	0.61	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	5.48	0.00	1.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.93	0.70	2.11	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	8.54	5.49	0.00	2.44	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.43	5.50	0.00	0.79	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.11	8.63	0.51	0.51	0.51	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	8.46	3.95	0.56	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	18.59	3.87	0.00	0.77	1.29	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	10.25	5.31	0.76	1.90	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	5.26	1.17	0.29	0.58	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.10	2.15	0.22	0.43	0.22	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	6.67	0.83	1.67	0.42	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.71	0.71	0.47	0.00	0.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.77	0.80	1.13	0.80	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	3.37	0.67	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.64	6.26	0.00	0.78	0.16	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	8.84	4.91	0.49	0.00	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	6.98	0.87	1.75	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	14.70	3.05	0.76	1.34	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.01	2.18	0.87	1.31	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	7.00	5.50	0.00	1.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.25	1.32	0.57	0.00	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	0.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	6.89	0.31	0.94	0.00	0.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.27	0.33	0.65	0.49	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	14.52	1.45	0.00	0.29	0.29	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.97	0.60	0.30	1.20	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	10.53	7.39	0.00	1.29	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	10.56	9.13	0.29	1.43	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.43	9.80	0.00	2.04	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	22.18	4.22	0.70	0.70	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	16.79	4.75	0.00	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	10.29	4.54	0.00	0.30	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	10.86	1.55	1.55	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.96	0.00	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	5.39	0.51	1.03	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.95	0.51	0.00	0.26	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.84	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.74	1.34	0.00	1.01	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	12.32	9.18	0.72	0.97	0.48	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.68	8.02	0.45	1.34	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.80	8.78	0.00	0.00	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	17.73	3.67	0.92	0.92	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	32.53	6.51	3.25	6.51	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	11.25	3.31	0.33	1.32	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	0.55	0.55	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.96	0.36	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.83	0.36	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	8.35	0.00	0.00	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.54	0.54	0.54	0.54	0.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.27	0.81	0.27	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	45.77	0.00	2.42	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	41.19	0.79	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	13.63	0.28	2.18	0.66	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	12.36	0.00	0.98	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	19.83	1.10	0.80	0.30	0.10	0.00
kidney, fetal, pool1	10045-101F9	32.82	1.77	1.91	0.85	0.57	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	69.87	11.93	1.99	0.43	1.14	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.68	0.83	0.41	0.83	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	22.57	2.39	0.18	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	15.26	0.00	0.00	0.54	1.09	0.00
left ventricle, adult, donor1	10078-102A6	10.62	0.00	0.00	0.00	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	42.41	1.64	0.27	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	13.29	1.08	0.36	1.08	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	15.76	4.89	1.09	1.09	0.00	2.17
leiomyoma cell line:15425	10571-108B4	12.63	2.67	0.24	0.97	1.46	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	3.66	0.00	0.47	0.00	0.24	0.00
liposarcoma cell line:KMLS-1	10782-110G8	18.28	5.00	0.78	0.78	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	57.63	3.17	0.85	0.73	0.61	0.37
liver, adult, pool1	10018-101C9	7.94	0.32	0.97	0.16	0.16	0.00
liver, fetal, pool1	10086-102B5	6.58	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	8.02	0.00	0.58	0.58	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	18.09	0.00	0.55	0.74	0.55	0.18
locus coeruleus, adult, donor10258	10375-105G6	5.08	0.00	0.28	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	10.52	0.00	0.42	0.84	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	21.59	4.57	1.66	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	4.14	0.00	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	84.10	2.77	2.50	1.05	0.92	0.26
lung, adult, pool1	10019-101D1	29.77	2.72	1.42	0.59	0.12	0.12
lung, fetal, donor1	10068-101I5	56.51	1.43	0.86	0.29	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	16.50	0.46	0.46	0.00	0.92	0.00
lymph node, adult, donor1	10077-102A5	20.35	0.95	0.47	0.00	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	1.97	0.00	0.88	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.04	0.00	0.45	0.15	0.60	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.00	1.70	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	51.95	5.33	0.44	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	54.37	3.53	0.42	0.00	0.21	0.00
mature adipocyte, donor3	12233-129G1	57.37	1.42	0.24	0.24	0.00	0.47
mature adipocyte, donor4	12234-129G2	60.54	2.11	0.79	0.26	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.15	9.77	0.48	0.24	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	25.38	0.18	0.37	0.92	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	3.81	0.00	0.64	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	14.50	0.00	2.99	1.28	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	11.31	0.17	1.35	2.53	1.52	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	28.86	0.21	2.12	0.00	0.85	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.61	0.36	1.79	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	11.68	0.00	0.65	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	26.94	0.31	1.08	0.62	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	13.06	0.41	1.80	0.08	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	6.60	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	39.63	2.44	0.22	3.54	0.22	0.66
medulloblastoma cell line:ONS-76	10759-110E3	22.25	0.86	0.12	0.24	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	15.96	1.15	0.00	0.29	0.00	0.14
melanoma cell line:G-361	10465-106H6	4.34	0.54	0.54	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	21.53	2.35	0.36	0.54	0.90	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	6.17	0.00	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	3.89	0.00	0.52	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	25.47	2.45	0.77	0.61	0.31	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.63	1.45	0.00	1.09	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	6.63	0.83	0.00	1.24	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.44	1.83	0.14	0.42	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	1.73	0.00	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	10.41	2.08	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.42	3.26	0.00	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.91	2.53	0.00	0.58	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.84	2.12	0.27	0.27	0.53	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.96	2.16	0.27	0.81	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.76	3.56	0.28	0.43	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.19	2.31	0.33	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	14.67	2.08	0.28	0.42	0.28	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.82	3.49	0.35	1.05	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.86	2.04	0.20	0.20	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	13.66	0.72	0.36	0.36	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	29.17	4.45	0.31	0.93	0.52	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.64	2.51	0.23	0.46	0.23	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	22.66	3.36	0.00	0.84	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.28	2.54	0.45	0.60	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.96	2.19	0.53	1.05	0.26	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.67	1.47	0.37	1.10	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.59	2.00	0.00	0.86	0.86	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.63	2.11	0.00	0.00	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	18.72	2.28	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	20.46	1.53	0.51	1.28	0.77	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.73	1.57	0.26	0.79	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	0.62	0.62	1.23	0.92	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	18.83	0.71	0.24	0.24	0.71	1.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.63	0.68	0.00	1.02	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	23.58	1.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.29	0.93	0.00	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	25.38	2.31	0.58	0.87	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.64	1.12	0.67	0.45	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	22.35	1.68	0.24	1.20	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	39.60	2.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	1.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	23.33	0.82	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	25.77	1.72	0.00	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	2.73	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.26	1.95	0.65	0.32	0.32	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	0.00	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	1.60	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.77	1.17	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	2.10	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	0.99	0.00	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	0.59	0.59	0.00	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	3.66	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.97	0.00	0.63	1.90	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.07	1.72	0.34	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	3.44	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	1.22	0.41	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	0.59	0.59	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	18.39	0.31	0.00	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	2.67	1.34	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	18.59	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.37	0.99	0.00	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	0.64	0.64	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.88	0.40	0.00	0.40	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	0.00	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	1.21	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	12.36	0.00	0.82	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	6.75	0.99	0.00	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	10.06	0.65	0.00	0.32	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	0.00	0.00	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	64.99	3.87	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	44.18	12.05	2.13	1.42	0.94	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	47.49	8.80	0.46	1.16	1.16	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.86	1.75	0.21	0.72	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	31.32	2.72	0.68	2.50	1.82	1.13
mesothelioma cell line:Mero-41	10851-111F5	20.29	0.24	0.49	0.98	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	18.82	1.99	0.44	0.66	0.89	0.44
mesothelioma cell line:Mero-82	10853-111F7	12.88	2.37	0.26	0.26	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	16.17	2.38	0.17	0.68	0.68	1.02
mesothelioma cell line:Mero-84	10855-111F9	29.83	3.29	1.77	2.78	1.77	1.52
mesothelioma cell line:Mero-95	10856-111G1	25.26	2.28	0.62	2.07	1.86	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	17.89	7.62	0.83	1.66	1.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	27.33	3.80	0.36	1.81	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	21.87	13.32	1.20	2.22	1.37	1.37
mesothelioma cell line:NCI-H28	10845-111E8	15.52	1.78	0.51	1.53	1.02	0.51
mesothelioma cell line:No36	10857-111G2	10.44	1.63	0.65	0.33	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	10.84	1.35	0.27	0.27	1.63	0.81
migratory langerhans cells, donor1	11901-125F2	14.01	0.19	2.88	0.77	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	14.65	0.00	2.93	0.00	0.00	0.49
migratory langerhans cells, donor3	11903-125F4	30.69	0.18	2.51	0.36	0.72	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	1.31	0.00	1.96	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.50	3.60	0.00	0.64	0.00	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	117.25	13.13	0.92	1.84	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.76	0.00	0.38	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	6.10	0.00	1.66	0.18	0.00	0.00
myeloma cell line:PCM6	10474-106I6	1.78	0.00	0.99	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.41	1.52	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.51	3.33	0.00	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	22.95	1.11	0.33	0.56	0.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	20.37	1.62	0.44	0.00	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	28.15	1.10	1.10	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	12.19	0.00	0.92	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	10.66	0.19	0.37	0.19	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	9.91	0.63	0.63	0.00	0.63	0.21
neuroblastoma cell line:NH-12	10555-107I6	32.98	0.19	0.56	0.37	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	22.77	1.66	0.47	2.14	0.71	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.20	0.63	0.16	0.48	0.48	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	9.66	2.01	0.20	0.20	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	5.09	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	26.88	0.27	0.53	0.00	0.00	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	4.40	0.00	1.18	0.00	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	0.00	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.95	0.96	0.00	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.33	1.58	1.84	1.05	0.53	1.05
nucleus accumbens, adult, pool1	10037-101F1	13.97	0.09	1.78	0.28	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	8.24	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	29.52	0.00	2.15	0.54	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	11.28	0.73	2.91	1.09	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	9.71	0.52	2.10	0.00	0.26	0.26
occipital lobe, fetal, donor1	10073-102A1	56.21	0.86	1.72	1.72	0.43	1.29
occipital pole, adult, pool1	10036-101E9	12.14	0.16	2.13	0.32	0.47	0.16
olfactory region, adult	10195-103E6	15.09	0.00	1.53	0.19	0.19	0.00
optic nerve, donor1	10277-104E7	4.00	0.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.44	4.67	0.57	0.91	0.80	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.85	0.41	0.14	0.14	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.68	0.85	0.17	1.19	1.19	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.92	1.73	0.46	1.39	1.04	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	29.40	2.35	0.59	0.29	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	2.80	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	16.96	2.12	0.42	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	33.63	1.75	0.79	0.52	0.70	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.75	1.65	0.37	0.73	0.55	0.18
pancreas, adult, donor1	10049-101G4	31.04	0.00	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.06	1.40	0.00	1.12	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	38.50	2.21	0.51	2.21	2.73	1.87
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.81	10.10	1.99	0.99	0.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	10.16	0.27	1.46	0.37	0.27	0.18
parietal cortex, adult, donor10258	10373-105G4	10.28	0.00	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	5.64	0.00	0.94	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	20.24	0.00	0.57	0.86	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	12.34	0.35	2.20	0.18	0.35	0.00
parietal lobe, fetal, donor1	10072-101I9	50.43	0.00	1.94	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	12.71	1.50	0.75	0.75	1.12	0.75
parotid gland, adult	10199-103F1	26.52	0.62	0.00	1.23	0.00	1.23
penis, adult	10200-103F2	32.23	1.07	0.54	0.54	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.69	0.37	0.19	0.74	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.97	1.02	0.15	1.31	1.17	0.29
pineal gland - adult, donor10196	10179-103C8	25.80	0.00	0.65	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	29.61	0.00	1.78	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	8.78	0.00	1.88	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	5.06	0.00	1.01	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	9.90	1.04	1.04	0.52	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	3.40	0.85	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	53.32	4.73	1.72	1.08	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	3.84	0.00	1.19	0.40	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.16	2.65	0.16	0.47	0.31	1.09
pons, adult, pool1	10033-101E6	7.23	0.17	0.95	0.09	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	9.85	0.17	1.57	0.44	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	6.27	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	24.33	4.95	1.02	2.04	1.75	1.02
prostate cancer cell line:PC-3	10439-106E7	31.22	4.72	2.00	0.91	1.09	0.36
prostate, adult, pool1	10022-101D4	31.56	1.09	1.18	0.54	0.36	0.09
putamen, adult, donor10196	10176-103C5	18.41	0.00	0.47	0.94	0.71	0.24
putamen, adult, donor10252	10152-102I8	11.76	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	6.56	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	5.80	0.00	0.72	1.93	0.97	0.24
putamen, newborn, donor10223	10365-105F5	3.75	0.00	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	86.41	5.53	0.87	0.58	0.58	0.00
rectum, fetal, donor1	10067-101I4	40.34	0.00	2.78	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	29.04	6.78	2.33	1.48	1.70	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.02	0.00	3.31	2.49	3.73	0.00
retina, adult, pool1	10030-101E3	33.99	1.89	1.59	0.60	0.60	0.20
retinoblastoma cell line:Y79	10475-106I7	5.98	0.00	0.52	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	22.01	0.25	0.61	0.61	0.25	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	61.86	9.00	0.56	1.12	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	56.84	6.06	0.00	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	27.19	0.32	0.16	0.97	0.32	0.16
salivary acinar cells, donor2	11772-123I8	40.34	0.83	0.41	1.38	1.65	1.79
salivary acinar cells, donor3	11773-123I9	111.89	1.99	0.66	2.65	0.00	0.00
salivary gland, adult, pool1	10093-102C3	28.03	0.57	1.72	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.44	3.63	1.26	0.76	0.51	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.46	4.58	1.06	0.71	0.35	0.12
seminal vesicle, adult	10201-103F3	31.22	0.00	0.00	1.59	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	28.42	1.70	0.24	1.21	0.97	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.61	0.25	0.50	0.50	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	1.00	0.00	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.67	2.69	0.94	1.34	0.54	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	23.65	9.28	0.55	0.55	0.66	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.10	11.35	1.55	0.65	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	0.71	0.71	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	23.51	1.08	0.60	0.48	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	44.22	1.01	1.01	0.00	4.02	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	69.43	0.63	0.63	1.89	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.33	0.00	0.00	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.64	0.95	0.32	1.89	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.05	0.77	1.35	0.39	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	0.99	0.00	0.49	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.66	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	23.75	2.83	0.87	1.31	0.87	0.22
small intestine, adult, pool1	10024-101D6	33.68	0.60	2.15	0.48	0.84	0.36
small intestine, fetal, donor1	10064-101I1	18.67	0.74	0.74	0.74	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	11.80	0.00	2.05	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	39.54	1.03	0.00	1.03	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	14.47	0.00	0.80	0.54	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	11.24	0.00	0.69	0.23	0.00	0.23
spinal cord, adult, donor10252	10159-103A6	23.26	0.00	0.79	0.39	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	2.77	0.00	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	28.66	0.61	1.83	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	10.10	0.00	0.00	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	42.57	4.18	0.75	1.34	0.75	0.00
spleen, adult, pool1	10025-101D7	15.75	0.99	1.54	0.00	0.33	0.11
spleen, fetal, pool1	10044-101F8	23.28	0.72	2.38	0.24	0.48	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	5.90	0.00	0.72	0.31	0.21	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.16	0.38	1.14	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	42.63	6.64	2.80	4.54	6.64	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	60.20	2.74	1.17	1.17	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	74.63	18.57	2.14	2.93	4.05	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	3.81	0.42	1.27	0.00	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.08	6.35	0.42	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	49.13	2.14	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	54.12	0.00	2.28	1.14	0.57	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	23.68	0.00	1.04	0.62	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	4.66	0.00	0.00	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	4.95	0.00	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	23.16	9.63	2.06	0.23	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	15.85	0.25	2.29	0.17	0.25	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	58.41	0.00	2.14	1.42	0.00	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	31.21	0.88	1.32	2.20	0.44	1.32
tenocyte, donor1	11763-123H8	36.66	2.44	0.35	3.49	3.84	1.40
tenocyte, donor2	11765-123I1	19.84	1.91	0.76	0.76	0.38	0.00
tenocyte, donor3	11768-123I4	18.16	1.48	0.00	0.74	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.69	0.85	0.85	0.34	0.34	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	19.42	11.41	0.00	1.08	1.39	0.31
teratocarcinoma cell line:PA-1	10807-111A6	15.50	4.03	0.15	0.62	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	24.25	7.62	0.38	1.14	1.14	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.16	3.03	0.00	1.13	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.24	8.83	0.98	2.07	0.65	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.17	0.33	0.33	0.65	0.65	0.65
testis, adult, pool1	10026-101D8	26.52	2.04	1.83	0.32	0.11	0.21
testis, adult, pool2	10096-102C6	18.04	0.45	1.35	3.16	0.90	0.90
thalamus - adult, donor10196	10168-103B6	9.94	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	21.72	0.00	2.03	0.63	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.27	0.00	0.00	0.16	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	1.73	0.00	0.00	0.58	0.00	0.00
throat, adult	10209-103G2	31.21	0.50	2.25	0.25	0.25	1.50
throat, fetal, donor1	10061-101H7	25.29	1.52	0.91	0.61	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	6.36	0.00	1.19	0.00	0.99	0.20
thymus, adult, pool1	10027-101D9	23.86	0.80	2.68	0.60	0.30	0.10
thymus, fetal, pool1	10043-101F7	32.00	0.73	3.12	0.73	0.31	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.11	3.99	0.53	0.13	0.53	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	53.08	2.79	0.28	1.40	1.68	0.42
thyroid, adult, pool1	10028-101E1	15.77	0.56	0.56	0.19	0.09	0.00
thyroid, fetal, donor1	10060-101H6	25.31	0.26	0.26	1.05	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	61.59	0.00	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	20.00	0.47	0.93	0.70	0.93	0.47
tongue, fetal, donor1	10059-101H5	30.35	0.39	1.18	0.39	0.39	0.00
tonsil, adult, pool1	10047-101G2	37.17	0.40	3.01	0.90	0.70	0.30
trachea, adult, pool1	10029-101E2	24.29	1.80	0.41	0.08	0.08	0.00
trachea, fetal, donor1	10058-101H4	28.47	0.38	0.77	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.55	3.19	0.35	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	18.03	0.61	0.30	0.30	0.41	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	16.92	4.23	0.78	0.94	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	76.10	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	23.96	1.35	1.02	0.51	0.59	0.17
umbilical cord, fetal, donor1	10057-101H3	50.08	4.17	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	41.29	1.37	0.51	0.34	0.85	0.17
uterus, fetal, donor1	10055-101H1	27.64	0.00	1.02	0.51	0.00	0.51
vagina, adult	10204-103F6	41.36	1.94	1.29	0.00	0.65	0.00
vein, adult	10191-103E2	25.21	0.22	0.44	0.44	0.88	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.87	0.00	0.53	0.53	0.27	0.27